nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—Cyclobenzaprine—Tamoxifen—breast cancer	0.256	1	CrCrCtD
Cyproheptadine—HTR6—Raloxifene—breast cancer	0.159	0.528	CbGbCtD
Cyproheptadine—HTR2B—Raloxifene—breast cancer	0.142	0.472	CbGbCtD
Cyproheptadine—CHRM3—muscle of abdomen—breast cancer	0.00554	0.233	CbGeAlD
Cyproheptadine—Ketotifen—PDE4D—breast cancer	0.00147	0.307	CrCbGaD
Cyproheptadine—UGT1A3—endocrine gland—breast cancer	0.00145	0.0612	CbGeAlD
Cyproheptadine—HTR2B—skin of body—breast cancer	0.000697	0.0293	CbGeAlD
Cyproheptadine—HRH1—nipple—breast cancer	0.000696	0.0293	CbGeAlD
Cyproheptadine—HTR2B—endometrium—breast cancer	0.000657	0.0276	CbGeAlD
Cyproheptadine—HTR2B—uterus—breast cancer	0.000605	0.0255	CbGeAlD
Cyproheptadine—HTR2B—adipose tissue—breast cancer	0.000592	0.0249	CbGeAlD
Cyproheptadine—HTR2C—female reproductive system—breast cancer	0.000579	0.0244	CbGeAlD
Cyproheptadine—CHRM1—female reproductive system—breast cancer	0.000547	0.023	CbGeAlD
Cyproheptadine—HTR2B—female reproductive system—breast cancer	0.000544	0.0229	CbGeAlD
Cyproheptadine—CHRM3—adipose tissue—breast cancer	0.000533	0.0224	CbGeAlD
Cyproheptadine—HTR2B—adrenal gland—breast cancer	0.000531	0.0223	CbGeAlD
Cyproheptadine—CHRM2—endocrine gland—breast cancer	0.000509	0.0214	CbGeAlD
Cyproheptadine—CHRM3—female reproductive system—breast cancer	0.00049	0.0206	CbGeAlD
Cyproheptadine—SLC6A2—female reproductive system—breast cancer	0.000483	0.0203	CbGeAlD
Cyproheptadine—DRD2—pituitary gland—breast cancer	0.000481	0.0202	CbGeAlD
Cyproheptadine—HTR2A—embryo—breast cancer	0.000479	0.0202	CbGeAlD
Cyproheptadine—HTR1A—adrenal gland—breast cancer	0.000476	0.02	CbGeAlD
Cyproheptadine—SLC6A2—adrenal gland—breast cancer	0.000472	0.0198	CbGeAlD
Cyproheptadine—HRH1—epithelium—breast cancer	0.000468	0.0197	CbGeAlD
Cyproheptadine—CHRM1—endocrine gland—breast cancer	0.000463	0.0195	CbGeAlD
Cyproheptadine—CHRM3—female gonad—breast cancer	0.000445	0.0187	CbGeAlD
Cyproheptadine—HRH1—endometrium—breast cancer	0.00042	0.0177	CbGeAlD
Cyproheptadine—CHRM3—endocrine gland—breast cancer	0.000414	0.0174	CbGeAlD
Cyproheptadine—HTR1A—endocrine gland—breast cancer	0.000413	0.0174	CbGeAlD
Cyproheptadine—SLC6A2—endocrine gland—breast cancer	0.000409	0.0172	CbGeAlD
Cyproheptadine—HTR2A—epithelium—breast cancer	0.000391	0.0165	CbGeAlD
Cyproheptadine—HRH1—adipose tissue—breast cancer	0.000378	0.0159	CbGeAlD
Cyproheptadine—DRD2—endocrine gland—breast cancer	0.000373	0.0157	CbGeAlD
Cyproheptadine—Azatadine—CYP3A4—breast cancer	0.000363	0.0761	CrCbGaD
Cyproheptadine—HRH1—female reproductive system—breast cancer	0.000348	0.0146	CbGeAlD
Cyproheptadine—HRH1—adrenal gland—breast cancer	0.00034	0.0143	CbGeAlD
Cyproheptadine—Protriptyline—CYP2D6—breast cancer	0.00033	0.0692	CrCbGaD
Cyproheptadine—HTR2B—lymph node—breast cancer	0.000318	0.0134	CbGeAlD
Cyproheptadine—HTR2A—pituitary gland—breast cancer	0.000317	0.0133	CbGeAlD
Cyproheptadine—HRH1—female gonad—breast cancer	0.000317	0.0133	CbGeAlD
Cyproheptadine—HRH1—endocrine gland—breast cancer	0.000294	0.0124	CbGeAlD
Cyproheptadine—HTR2A—female reproductive system—breast cancer	0.000291	0.0122	CbGeAlD
Cyproheptadine—HTR2A—adrenal gland—breast cancer	0.000284	0.0119	CbGeAlD
Cyproheptadine—SLC6A2—lymph node—breast cancer	0.000283	0.0119	CbGeAlD
Cyproheptadine—Cyclobenzaprine—CYP2D6—breast cancer	0.000247	0.0517	CrCbGaD
Cyproheptadine—HTR2A—endocrine gland—breast cancer	0.000246	0.0103	CbGeAlD
Cyproheptadine—Protriptyline—ABCB1—breast cancer	0.000236	0.0494	CrCbGaD
Cyproheptadine—Clozapine—CYP1B1—breast cancer	0.000235	0.0493	CrCbGaD
Cyproheptadine—Cyclobenzaprine—CYP3A4—breast cancer	0.000212	0.0443	CrCbGaD
Cyproheptadine—HRH1—lymph node—breast cancer	0.000204	0.00856	CbGeAlD
Cyproheptadine—Nausea—Goserelin—breast cancer	0.0002	0.000768	CcSEcCtD
Cyproheptadine—Feeling abnormal—Gemcitabine—breast cancer	0.0002	0.000766	CcSEcCtD
Cyproheptadine—Shock—Paclitaxel—breast cancer	0.000199	0.000766	CcSEcCtD
Cyproheptadine—Dizziness—Vinorelbine—breast cancer	0.000199	0.000765	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Methotrexate—breast cancer	0.000199	0.000763	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Paclitaxel—breast cancer	0.000199	0.000762	CcSEcCtD
Cyproheptadine—Tachycardia—Paclitaxel—breast cancer	0.000198	0.00076	CcSEcCtD
Cyproheptadine—Urticaria—Mitoxantrone—breast cancer	0.000197	0.000758	CcSEcCtD
Cyproheptadine—Diarrhoea—Thiotepa—breast cancer	0.000197	0.000756	CcSEcCtD
Cyproheptadine—Feeling abnormal—Fluorouracil—breast cancer	0.000196	0.000753	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Paclitaxel—breast cancer	0.000196	0.000753	CcSEcCtD
Cyproheptadine—Drowsiness—Methotrexate—breast cancer	0.000194	0.000746	CcSEcCtD
Cyproheptadine—Anorexia—Paclitaxel—breast cancer	0.000193	0.000742	CcSEcCtD
Cyproheptadine—Vision blurred—Capecitabine—breast cancer	0.000192	0.000738	CcSEcCtD
Cyproheptadine—Vomiting—Vinorelbine—breast cancer	0.000192	0.000736	CcSEcCtD
Cyproheptadine—Tremor—Capecitabine—breast cancer	0.000191	0.000733	CcSEcCtD
Cyproheptadine—Dizziness—Thiotepa—breast cancer	0.00019	0.000731	CcSEcCtD
Cyproheptadine—Rash—Vinorelbine—breast cancer	0.00019	0.00073	CcSEcCtD
Cyproheptadine—Dermatitis—Vinorelbine—breast cancer	0.00019	0.000729	CcSEcCtD
Cyproheptadine—Hypotension—Paclitaxel—breast cancer	0.000189	0.000728	CcSEcCtD
Cyproheptadine—Urticaria—Fluorouracil—breast cancer	0.000189	0.000726	CcSEcCtD
Cyproheptadine—Headache—Vinorelbine—breast cancer	0.000189	0.000725	CcSEcCtD
Cyproheptadine—Syncope—Docetaxel—breast cancer	0.000189	0.000725	CcSEcCtD
Cyproheptadine—Leukopenia—Docetaxel—breast cancer	0.000188	0.000724	CcSEcCtD
Cyproheptadine—Pollakiuria—Epirubicin—breast cancer	0.000188	0.000723	CcSEcCtD
Cyproheptadine—Palpitations—Docetaxel—breast cancer	0.000186	0.000715	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Epirubicin—breast cancer	0.000186	0.000714	CcSEcCtD
Cyproheptadine—Nortriptyline—PTGS1—breast cancer	0.000186	0.039	CrCbGaD
Cyproheptadine—Weight increased—Epirubicin—breast cancer	0.000185	0.000712	CcSEcCtD
Cyproheptadine—Loss of consciousness—Docetaxel—breast cancer	0.000185	0.000711	CcSEcCtD
Cyproheptadine—Insomnia—Paclitaxel—breast cancer	0.000183	0.000704	CcSEcCtD
Cyproheptadine—Vertigo—Capecitabine—breast cancer	0.000183	0.000703	CcSEcCtD
Cyproheptadine—Vomiting—Thiotepa—breast cancer	0.000183	0.000703	CcSEcCtD
Cyproheptadine—Syncope—Capecitabine—breast cancer	0.000183	0.000702	CcSEcCtD
Cyproheptadine—Leukopenia—Capecitabine—breast cancer	0.000182	0.000701	CcSEcCtD
Cyproheptadine—Convulsion—Docetaxel—breast cancer	0.000182	0.000701	CcSEcCtD
Cyproheptadine—Paraesthesia—Paclitaxel—breast cancer	0.000182	0.000699	CcSEcCtD
Cyproheptadine—Drowsiness—Epirubicin—breast cancer	0.000182	0.000698	CcSEcCtD
Cyproheptadine—Rash—Thiotepa—breast cancer	0.000181	0.000697	CcSEcCtD
Cyproheptadine—Dermatitis—Thiotepa—breast cancer	0.000181	0.000696	CcSEcCtD
Cyproheptadine—Agranulocytosis—Methotrexate—breast cancer	0.000181	0.000696	CcSEcCtD
Cyproheptadine—Headache—Thiotepa—breast cancer	0.00018	0.000693	CcSEcCtD
Cyproheptadine—Somnolence—Paclitaxel—breast cancer	0.00018	0.000692	CcSEcCtD
Cyproheptadine—Palpitations—Capecitabine—breast cancer	0.00018	0.000692	CcSEcCtD
Cyproheptadine—Loss of consciousness—Capecitabine—breast cancer	0.000179	0.000688	CcSEcCtD
Cyproheptadine—Nausea—Vinorelbine—breast cancer	0.000179	0.000688	CcSEcCtD
Cyproheptadine—Dyspepsia—Paclitaxel—breast cancer	0.000178	0.000685	CcSEcCtD
Cyproheptadine—Asthenia—Irinotecan—breast cancer	0.000178	0.000685	CcSEcCtD
Cyproheptadine—Asthenia—Mitoxantrone—breast cancer	0.000178	0.000685	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Epirubicin—breast cancer	0.000178	0.000684	CcSEcCtD
Cyproheptadine—Jaundice—Epirubicin—breast cancer	0.000177	0.00068	CcSEcCtD
Cyproheptadine—Decreased appetite—Paclitaxel—breast cancer	0.000176	0.000677	CcSEcCtD
Cyproheptadine—Fatigue—Paclitaxel—breast cancer	0.000175	0.000671	CcSEcCtD
Cyproheptadine—Hepatitis—Methotrexate—breast cancer	0.000174	0.000669	CcSEcCtD
Cyproheptadine—Pollakiuria—Doxorubicin—breast cancer	0.000174	0.000669	CcSEcCtD
Cyproheptadine—Asthenia—Gemcitabine—breast cancer	0.000174	0.000667	CcSEcCtD
Cyproheptadine—Constipation—Paclitaxel—breast cancer	0.000173	0.000666	CcSEcCtD
Cyproheptadine—Confusional state—Docetaxel—breast cancer	0.000173	0.000665	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Doxorubicin—breast cancer	0.000172	0.000661	CcSEcCtD
Cyproheptadine—Oedema—Docetaxel—breast cancer	0.000172	0.00066	CcSEcCtD
Cyproheptadine—Weight increased—Doxorubicin—breast cancer	0.000172	0.000659	CcSEcCtD
Cyproheptadine—Nausea—Thiotepa—breast cancer	0.000171	0.000657	CcSEcCtD
Cyproheptadine—Diarrhoea—Irinotecan—breast cancer	0.00017	0.000653	CcSEcCtD
Cyproheptadine—Diarrhoea—Mitoxantrone—breast cancer	0.00017	0.000653	CcSEcCtD
Cyproheptadine—Agranulocytosis—Epirubicin—breast cancer	0.00017	0.000651	CcSEcCtD
Cyproheptadine—Shock—Docetaxel—breast cancer	0.000169	0.000649	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Docetaxel—breast cancer	0.000168	0.000646	CcSEcCtD
Cyproheptadine—Drowsiness—Doxorubicin—breast cancer	0.000168	0.000646	CcSEcCtD
Cyproheptadine—Confusional state—Capecitabine—breast cancer	0.000168	0.000644	CcSEcCtD
Cyproheptadine—Tachycardia—Docetaxel—breast cancer	0.000168	0.000644	CcSEcCtD
Cyproheptadine—Feeling abnormal—Paclitaxel—breast cancer	0.000167	0.000642	CcSEcCtD
Cyproheptadine—Oedema—Capecitabine—breast cancer	0.000166	0.000639	CcSEcCtD
Cyproheptadine—Diarrhoea—Gemcitabine—breast cancer	0.000166	0.000636	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Doxorubicin—breast cancer	0.000165	0.000633	CcSEcCtD
Cyproheptadine—Dizziness—Irinotecan—breast cancer	0.000164	0.000631	CcSEcCtD
Cyproheptadine—Jaundice—Doxorubicin—breast cancer	0.000164	0.000629	CcSEcCtD
Cyproheptadine—Anorexia—Docetaxel—breast cancer	0.000164	0.000629	CcSEcCtD
Cyproheptadine—Shock—Capecitabine—breast cancer	0.000164	0.000629	CcSEcCtD
Cyproheptadine—Hepatitis—Epirubicin—breast cancer	0.000163	0.000627	CcSEcCtD
Cyproheptadine—Diarrhoea—Fluorouracil—breast cancer	0.000163	0.000626	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Capecitabine—breast cancer	0.000163	0.000626	CcSEcCtD
Cyproheptadine—Tinnitus—Methotrexate—breast cancer	0.000163	0.000624	CcSEcCtD
Cyproheptadine—Tachycardia—Capecitabine—breast cancer	0.000162	0.000624	CcSEcCtD
Cyproheptadine—Urticaria—Paclitaxel—breast cancer	0.000161	0.000619	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Capecitabine—breast cancer	0.000161	0.000618	CcSEcCtD
Cyproheptadine—Hypotension—Docetaxel—breast cancer	0.000161	0.000617	CcSEcCtD
Cyproheptadine—Anorexia—Capecitabine—breast cancer	0.000159	0.000609	CcSEcCtD
Cyproheptadine—Vomiting—Mitoxantrone—breast cancer	0.000158	0.000607	CcSEcCtD
Cyproheptadine—Vomiting—Irinotecan—breast cancer	0.000158	0.000607	CcSEcCtD
Cyproheptadine—Dizziness—Fluorouracil—breast cancer	0.000157	0.000605	CcSEcCtD
Cyproheptadine—Agranulocytosis—Doxorubicin—breast cancer	0.000157	0.000603	CcSEcCtD
Cyproheptadine—Rash—Irinotecan—breast cancer	0.000157	0.000602	CcSEcCtD
Cyproheptadine—Rash—Mitoxantrone—breast cancer	0.000157	0.000602	CcSEcCtD
Cyproheptadine—Dermatitis—Irinotecan—breast cancer	0.000157	0.000601	CcSEcCtD
Cyproheptadine—Dermatitis—Mitoxantrone—breast cancer	0.000157	0.000601	CcSEcCtD
Cyproheptadine—Chills—Methotrexate—breast cancer	0.000156	0.000601	CcSEcCtD
Cyproheptadine—Headache—Irinotecan—breast cancer	0.000156	0.000598	CcSEcCtD
Cyproheptadine—Headache—Mitoxantrone—breast cancer	0.000156	0.000598	CcSEcCtD
Cyproheptadine—Hypotension—Capecitabine—breast cancer	0.000155	0.000597	CcSEcCtD
Cyproheptadine—Insomnia—Docetaxel—breast cancer	0.000155	0.000597	CcSEcCtD
Cyproheptadine—Paraesthesia—Docetaxel—breast cancer	0.000154	0.000593	CcSEcCtD
Cyproheptadine—Vomiting—Gemcitabine—breast cancer	0.000154	0.000591	CcSEcCtD
Cyproheptadine—Somnolence—Docetaxel—breast cancer	0.000153	0.000587	CcSEcCtD
Cyproheptadine—Rash—Gemcitabine—breast cancer	0.000153	0.000586	CcSEcCtD
Cyproheptadine—Dermatitis—Gemcitabine—breast cancer	0.000153	0.000586	CcSEcCtD
Cyproheptadine—Tinnitus—Epirubicin—breast cancer	0.000152	0.000584	CcSEcCtD
Cyproheptadine—Headache—Gemcitabine—breast cancer	0.000152	0.000583	CcSEcCtD
Cyproheptadine—Vomiting—Fluorouracil—breast cancer	0.000151	0.000581	CcSEcCtD
Cyproheptadine—Dyspepsia—Docetaxel—breast cancer	0.000151	0.000581	CcSEcCtD
Cyproheptadine—Hepatitis—Doxorubicin—breast cancer	0.000151	0.00058	CcSEcCtD
Cyproheptadine—Insomnia—Capecitabine—breast cancer	0.00015	0.000578	CcSEcCtD
Cyproheptadine—Rash—Fluorouracil—breast cancer	0.00015	0.000577	CcSEcCtD
Cyproheptadine—Dermatitis—Fluorouracil—breast cancer	0.00015	0.000576	CcSEcCtD
Cyproheptadine—Paraesthesia—Capecitabine—breast cancer	0.000149	0.000574	CcSEcCtD
Cyproheptadine—Decreased appetite—Docetaxel—breast cancer	0.000149	0.000574	CcSEcCtD
Cyproheptadine—Headache—Fluorouracil—breast cancer	0.000149	0.000573	CcSEcCtD
Cyproheptadine—Fatigue—Docetaxel—breast cancer	0.000148	0.000569	CcSEcCtD
Cyproheptadine—Nausea—Mitoxantrone—breast cancer	0.000148	0.000567	CcSEcCtD
Cyproheptadine—Nausea—Irinotecan—breast cancer	0.000148	0.000567	CcSEcCtD
Cyproheptadine—Constipation—Docetaxel—breast cancer	0.000147	0.000564	CcSEcCtD
Cyproheptadine—Dyspepsia—Capecitabine—breast cancer	0.000146	0.000562	CcSEcCtD
Cyproheptadine—Chills—Epirubicin—breast cancer	0.000146	0.000562	CcSEcCtD
Cyproheptadine—Asthenia—Paclitaxel—breast cancer	0.000145	0.000559	CcSEcCtD
Cyproheptadine—Decreased appetite—Capecitabine—breast cancer	0.000145	0.000555	CcSEcCtD
Cyproheptadine—Nausea—Gemcitabine—breast cancer	0.000144	0.000552	CcSEcCtD
Cyproheptadine—Fatigue—Capecitabine—breast cancer	0.000143	0.000551	CcSEcCtD
Cyproheptadine—Vision blurred—Methotrexate—breast cancer	0.000143	0.000549	CcSEcCtD
Cyproheptadine—Constipation—Capecitabine—breast cancer	0.000142	0.000546	CcSEcCtD
Cyproheptadine—Mianserin—CYP2D6—breast cancer	0.000142	0.0297	CrCbGaD
Cyproheptadine—Feeling abnormal—Docetaxel—breast cancer	0.000142	0.000544	CcSEcCtD
Cyproheptadine—Nausea—Fluorouracil—breast cancer	0.000141	0.000543	CcSEcCtD
Cyproheptadine—Tinnitus—Doxorubicin—breast cancer	0.000141	0.000541	CcSEcCtD
Cyproheptadine—Tension—Epirubicin—breast cancer	0.000139	0.000535	CcSEcCtD
Cyproheptadine—Diarrhoea—Paclitaxel—breast cancer	0.000139	0.000533	CcSEcCtD
Cyproheptadine—Nervousness—Epirubicin—breast cancer	0.000138	0.00053	CcSEcCtD
Cyproheptadine—Feeling abnormal—Capecitabine—breast cancer	0.000137	0.000527	CcSEcCtD
Cyproheptadine—Vertigo—Methotrexate—breast cancer	0.000136	0.000524	CcSEcCtD
Cyproheptadine—Leukopenia—Methotrexate—breast cancer	0.000136	0.000522	CcSEcCtD
Cyproheptadine—Chills—Doxorubicin—breast cancer	0.000135	0.00052	CcSEcCtD
Cyproheptadine—Dizziness—Paclitaxel—breast cancer	0.000134	0.000515	CcSEcCtD
Cyproheptadine—Vision blurred—Epirubicin—breast cancer	0.000134	0.000514	CcSEcCtD
Cyproheptadine—Urticaria—Capecitabine—breast cancer	0.000132	0.000508	CcSEcCtD
Cyproheptadine—Carbamazepine—CYP3A4—breast cancer	0.000132	0.0276	CrCbGaD
Cyproheptadine—Convulsion—Methotrexate—breast cancer	0.000131	0.000505	CcSEcCtD
Cyproheptadine—Agitation—Epirubicin—breast cancer	0.000131	0.000501	CcSEcCtD
Cyproheptadine—Tension—Doxorubicin—breast cancer	0.000129	0.000495	CcSEcCtD
Cyproheptadine—Vomiting—Paclitaxel—breast cancer	0.000129	0.000495	CcSEcCtD
Cyproheptadine—Rash—Paclitaxel—breast cancer	0.000128	0.000491	CcSEcCtD
Cyproheptadine—Dermatitis—Paclitaxel—breast cancer	0.000128	0.00049	CcSEcCtD
Cyproheptadine—Nervousness—Doxorubicin—breast cancer	0.000128	0.00049	CcSEcCtD
Cyproheptadine—Vertigo—Epirubicin—breast cancer	0.000128	0.00049	CcSEcCtD
Cyproheptadine—Syncope—Epirubicin—breast cancer	0.000127	0.000489	CcSEcCtD
Cyproheptadine—Leukopenia—Epirubicin—breast cancer	0.000127	0.000488	CcSEcCtD
Cyproheptadine—Headache—Paclitaxel—breast cancer	0.000127	0.000488	CcSEcCtD
Cyproheptadine—Clozapine—CYP1A1—breast cancer	0.000127	0.0266	CrCbGaD
Cyproheptadine—Nortriptyline—CYP2D6—breast cancer	0.000127	0.0265	CrCbGaD
Cyproheptadine—Palpitations—Epirubicin—breast cancer	0.000126	0.000482	CcSEcCtD
Cyproheptadine—Confusional state—Methotrexate—breast cancer	0.000125	0.00048	CcSEcCtD
Cyproheptadine—Loss of consciousness—Epirubicin—breast cancer	0.000125	0.000479	CcSEcCtD
Cyproheptadine—Vision blurred—Doxorubicin—breast cancer	0.000124	0.000476	CcSEcCtD
Cyproheptadine—Asthenia—Docetaxel—breast cancer	0.000123	0.000473	CcSEcCtD
Cyproheptadine—Convulsion—Epirubicin—breast cancer	0.000123	0.000473	CcSEcCtD
Cyproheptadine—Mianserin—CYP3A4—breast cancer	0.000121	0.0255	CrCbGaD
Cyproheptadine—Thrombocytopenia—Methotrexate—breast cancer	0.000121	0.000466	CcSEcCtD
Cyproheptadine—Agitation—Doxorubicin—breast cancer	0.000121	0.000464	CcSEcCtD
Cyproheptadine—Nausea—Paclitaxel—breast cancer	0.00012	0.000462	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Methotrexate—breast cancer	0.00012	0.00046	CcSEcCtD
Cyproheptadine—Asthenia—Capecitabine—breast cancer	0.000119	0.000458	CcSEcCtD
Cyproheptadine—Vertigo—Doxorubicin—breast cancer	0.000118	0.000453	CcSEcCtD
Cyproheptadine—Anorexia—Methotrexate—breast cancer	0.000118	0.000453	CcSEcCtD
Cyproheptadine—Syncope—Doxorubicin—breast cancer	0.000118	0.000453	CcSEcCtD
Cyproheptadine—Leukopenia—Doxorubicin—breast cancer	0.000118	0.000452	CcSEcCtD
Cyproheptadine—Diarrhoea—Docetaxel—breast cancer	0.000118	0.000452	CcSEcCtD
Cyproheptadine—Confusional state—Epirubicin—breast cancer	0.000117	0.000449	CcSEcCtD
Cyproheptadine—Palpitations—Doxorubicin—breast cancer	0.000116	0.000446	CcSEcCtD
Cyproheptadine—Oedema—Epirubicin—breast cancer	0.000116	0.000445	CcSEcCtD
Cyproheptadine—Hypotension—Methotrexate—breast cancer	0.000116	0.000444	CcSEcCtD
Cyproheptadine—Loss of consciousness—Doxorubicin—breast cancer	0.000115	0.000444	CcSEcCtD
Cyproheptadine—Shock—Epirubicin—breast cancer	0.000114	0.000438	CcSEcCtD
Cyproheptadine—Convulsion—Doxorubicin—breast cancer	0.000114	0.000437	CcSEcCtD
Cyproheptadine—Diarrhoea—Capecitabine—breast cancer	0.000114	0.000437	CcSEcCtD
Cyproheptadine—Dizziness—Docetaxel—breast cancer	0.000114	0.000436	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Epirubicin—breast cancer	0.000113	0.000436	CcSEcCtD
Cyproheptadine—Tachycardia—Epirubicin—breast cancer	0.000113	0.000434	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Epirubicin—breast cancer	0.000112	0.00043	CcSEcCtD
Cyproheptadine—Insomnia—Methotrexate—breast cancer	0.000112	0.00043	CcSEcCtD
Cyproheptadine—Paraesthesia—Methotrexate—breast cancer	0.000111	0.000427	CcSEcCtD
Cyproheptadine—Anorexia—Epirubicin—breast cancer	0.00011	0.000424	CcSEcCtD
Cyproheptadine—Somnolence—Methotrexate—breast cancer	0.00011	0.000423	CcSEcCtD
Cyproheptadine—Dizziness—Capecitabine—breast cancer	0.00011	0.000423	CcSEcCtD
Cyproheptadine—Carbamazepine—ABCB1—breast cancer	0.00011	0.023	CrCbGaD
Cyproheptadine—Vomiting—Docetaxel—breast cancer	0.000109	0.00042	CcSEcCtD
Cyproheptadine—Dyspepsia—Methotrexate—breast cancer	0.000109	0.000419	CcSEcCtD
Cyproheptadine—Nortriptyline—CYP3A4—breast cancer	0.000109	0.0228	CrCbGaD
Cyproheptadine—Rash—Docetaxel—breast cancer	0.000108	0.000416	CcSEcCtD
Cyproheptadine—Hypotension—Epirubicin—breast cancer	0.000108	0.000416	CcSEcCtD
Cyproheptadine—Dermatitis—Docetaxel—breast cancer	0.000108	0.000416	CcSEcCtD
Cyproheptadine—Confusional state—Doxorubicin—breast cancer	0.000108	0.000415	CcSEcCtD
Cyproheptadine—Decreased appetite—Methotrexate—breast cancer	0.000108	0.000413	CcSEcCtD
Cyproheptadine—Headache—Docetaxel—breast cancer	0.000108	0.000413	CcSEcCtD
Cyproheptadine—Oedema—Doxorubicin—breast cancer	0.000107	0.000412	CcSEcCtD
Cyproheptadine—Fatigue—Methotrexate—breast cancer	0.000107	0.00041	CcSEcCtD
Cyproheptadine—Vomiting—Capecitabine—breast cancer	0.000106	0.000406	CcSEcCtD
Cyproheptadine—Shock—Doxorubicin—breast cancer	0.000106	0.000405	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Doxorubicin—breast cancer	0.000105	0.000403	CcSEcCtD
Cyproheptadine—Rash—Capecitabine—breast cancer	0.000105	0.000403	CcSEcCtD
Cyproheptadine—Insomnia—Epirubicin—breast cancer	0.000105	0.000403	CcSEcCtD
Cyproheptadine—Dermatitis—Capecitabine—breast cancer	0.000105	0.000402	CcSEcCtD
Cyproheptadine—Tachycardia—Doxorubicin—breast cancer	0.000105	0.000402	CcSEcCtD
Cyproheptadine—Headache—Capecitabine—breast cancer	0.000104	0.0004	CcSEcCtD
Cyproheptadine—Paraesthesia—Epirubicin—breast cancer	0.000104	0.0004	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Doxorubicin—breast cancer	0.000104	0.000398	CcSEcCtD
Cyproheptadine—Somnolence—Epirubicin—breast cancer	0.000103	0.000396	CcSEcCtD
Cyproheptadine—Anorexia—Doxorubicin—breast cancer	0.000102	0.000393	CcSEcCtD
Cyproheptadine—Nausea—Docetaxel—breast cancer	0.000102	0.000392	CcSEcCtD
Cyproheptadine—Feeling abnormal—Methotrexate—breast cancer	0.000102	0.000392	CcSEcCtD
Cyproheptadine—Dyspepsia—Epirubicin—breast cancer	0.000102	0.000392	CcSEcCtD
Cyproheptadine—Decreased appetite—Epirubicin—breast cancer	0.000101	0.000387	CcSEcCtD
Cyproheptadine—Hypotension—Doxorubicin—breast cancer	0.0001	0.000385	CcSEcCtD
Cyproheptadine—Fatigue—Epirubicin—breast cancer	9.99e-05	0.000384	CcSEcCtD
Cyproheptadine—Constipation—Epirubicin—breast cancer	9.91e-05	0.000381	CcSEcCtD
Cyproheptadine—Nausea—Capecitabine—breast cancer	9.88e-05	0.00038	CcSEcCtD
Cyproheptadine—Urticaria—Methotrexate—breast cancer	9.84e-05	0.000378	CcSEcCtD
Cyproheptadine—Insomnia—Doxorubicin—breast cancer	9.7e-05	0.000373	CcSEcCtD
Cyproheptadine—Paraesthesia—Doxorubicin—breast cancer	9.63e-05	0.00037	CcSEcCtD
Cyproheptadine—Feeling abnormal—Epirubicin—breast cancer	9.55e-05	0.000367	CcSEcCtD
Cyproheptadine—Somnolence—Doxorubicin—breast cancer	9.53e-05	0.000366	CcSEcCtD
Cyproheptadine—Nortriptyline—ALB—breast cancer	9.47e-05	0.0199	CrCbGaD
Cyproheptadine—Clozapine—CYP2D6—breast cancer	9.45e-05	0.0198	CrCbGaD
Cyproheptadine—Dyspepsia—Doxorubicin—breast cancer	9.44e-05	0.000363	CcSEcCtD
Cyproheptadine—Decreased appetite—Doxorubicin—breast cancer	9.32e-05	0.000358	CcSEcCtD
Cyproheptadine—Fatigue—Doxorubicin—breast cancer	9.25e-05	0.000355	CcSEcCtD
Cyproheptadine—Urticaria—Epirubicin—breast cancer	9.21e-05	0.000354	CcSEcCtD
Cyproheptadine—Constipation—Doxorubicin—breast cancer	9.17e-05	0.000352	CcSEcCtD
Cyproheptadine—Asthenia—Methotrexate—breast cancer	8.89e-05	0.000341	CcSEcCtD
Cyproheptadine—Feeling abnormal—Doxorubicin—breast cancer	8.84e-05	0.000339	CcSEcCtD
Cyproheptadine—Amitriptyline—CYP2D6—breast cancer	8.78e-05	0.0184	CrCbGaD
Cyproheptadine—Urticaria—Doxorubicin—breast cancer	8.52e-05	0.000327	CcSEcCtD
Cyproheptadine—Diarrhoea—Methotrexate—breast cancer	8.47e-05	0.000325	CcSEcCtD
Cyproheptadine—Asthenia—Epirubicin—breast cancer	8.32e-05	0.000319	CcSEcCtD
Cyproheptadine—Dizziness—Methotrexate—breast cancer	8.19e-05	0.000315	CcSEcCtD
Cyproheptadine—Clozapine—CYP3A4—breast cancer	8.1e-05	0.017	CrCbGaD
Cyproheptadine—Diarrhoea—Epirubicin—breast cancer	7.93e-05	0.000305	CcSEcCtD
Cyproheptadine—Vomiting—Methotrexate—breast cancer	7.87e-05	0.000302	CcSEcCtD
Cyproheptadine—Rash—Methotrexate—breast cancer	7.81e-05	0.0003	CcSEcCtD
Cyproheptadine—Dermatitis—Methotrexate—breast cancer	7.8e-05	0.0003	CcSEcCtD
Cyproheptadine—Headache—Methotrexate—breast cancer	7.76e-05	0.000298	CcSEcCtD
Cyproheptadine—Asthenia—Doxorubicin—breast cancer	7.69e-05	0.000296	CcSEcCtD
Cyproheptadine—Dizziness—Epirubicin—breast cancer	7.66e-05	0.000294	CcSEcCtD
Cyproheptadine—Amitriptyline—CYP3A4—breast cancer	7.54e-05	0.0158	CrCbGaD
Cyproheptadine—Vomiting—Epirubicin—breast cancer	7.37e-05	0.000283	CcSEcCtD
Cyproheptadine—Nausea—Methotrexate—breast cancer	7.36e-05	0.000283	CcSEcCtD
Cyproheptadine—Diarrhoea—Doxorubicin—breast cancer	7.34e-05	0.000282	CcSEcCtD
Cyproheptadine—Rash—Epirubicin—breast cancer	7.31e-05	0.000281	CcSEcCtD
Cyproheptadine—Dermatitis—Epirubicin—breast cancer	7.3e-05	0.00028	CcSEcCtD
Cyproheptadine—Headache—Epirubicin—breast cancer	7.26e-05	0.000279	CcSEcCtD
Cyproheptadine—Dizziness—Doxorubicin—breast cancer	7.09e-05	0.000272	CcSEcCtD
Cyproheptadine—Nausea—Epirubicin—breast cancer	6.88e-05	0.000264	CcSEcCtD
Cyproheptadine—Vomiting—Doxorubicin—breast cancer	6.82e-05	0.000262	CcSEcCtD
Cyproheptadine—Rash—Doxorubicin—breast cancer	6.76e-05	0.00026	CcSEcCtD
Cyproheptadine—Dermatitis—Doxorubicin—breast cancer	6.76e-05	0.000259	CcSEcCtD
Cyproheptadine—Clozapine—ABCB1—breast cancer	6.75e-05	0.0141	CrCbGaD
Cyproheptadine—Headache—Doxorubicin—breast cancer	6.72e-05	0.000258	CcSEcCtD
Cyproheptadine—Amitriptyline—ALB—breast cancer	6.57e-05	0.0138	CrCbGaD
Cyproheptadine—Nausea—Doxorubicin—breast cancer	6.37e-05	0.000245	CcSEcCtD
Cyproheptadine—Amitriptyline—ABCB1—breast cancer	6.27e-05	0.0131	CrCbGaD
Cyproheptadine—HTR2B—Signaling Pathways—TGFB1—breast cancer	4.66e-06	3.02e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MDM2—breast cancer	4.66e-06	3.02e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—RAF1—breast cancer	4.66e-06	3.02e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CTNNB1—breast cancer	4.65e-06	3.01e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—RELA—breast cancer	4.65e-06	3.01e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MDM2—breast cancer	4.64e-06	3.01e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—RAF1—breast cancer	4.64e-06	3.01e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—RELA—breast cancer	4.64e-06	3e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3CB—breast cancer	4.63e-06	3e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MTOR—breast cancer	4.63e-06	3e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—RAF1—breast cancer	4.63e-06	3e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—RELA—breast cancer	4.62e-06	2.99e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—ERBB2—breast cancer	4.62e-06	2.99e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	4.62e-06	2.99e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—ERBB2—breast cancer	4.61e-06	2.98e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—RELA—breast cancer	4.61e-06	2.98e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MDM2—breast cancer	4.6e-06	2.98e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—ERBB2—breast cancer	4.59e-06	2.98e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MMP9—breast cancer	4.59e-06	2.97e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—RAF1—breast cancer	4.58e-06	2.97e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—ERBB2—breast cancer	4.58e-06	2.97e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—EGFR—breast cancer	4.57e-06	2.96e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CDKN1A—breast cancer	4.57e-06	2.96e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—RELA—breast cancer	4.56e-06	2.96e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MMP9—breast cancer	4.56e-06	2.95e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PTEN—breast cancer	4.56e-06	2.95e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MTOR—breast cancer	4.56e-06	2.95e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3CB—breast cancer	4.56e-06	2.95e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3CB—breast cancer	4.55e-06	2.95e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MTOR—breast cancer	4.55e-06	2.95e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CDKN1A—breast cancer	4.55e-06	2.94e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PTEN—breast cancer	4.54e-06	2.94e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—ERBB2—breast cancer	4.53e-06	2.94e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MTOR—breast cancer	4.53e-06	2.94e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3CB—breast cancer	4.53e-06	2.94e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MTOR—breast cancer	4.52e-06	2.93e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3CB—breast cancer	4.52e-06	2.93e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MTOR—breast cancer	4.47e-06	2.9e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CB—breast cancer	4.47e-06	2.9e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MAPK8—breast cancer	4.46e-06	2.89e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CXCL8—breast cancer	4.45e-06	2.88e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—AKT1—breast cancer	4.45e-06	2.88e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MAPK8—breast cancer	4.44e-06	2.87e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—AKT1—breast cancer	4.42e-06	2.87e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—HRAS—breast cancer	4.42e-06	2.86e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CXCL8—breast cancer	4.38e-06	2.84e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CXCL8—breast cancer	4.37e-06	2.83e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CXCL8—breast cancer	4.36e-06	2.82e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—HRAS—breast cancer	4.35e-06	2.82e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CDKN1B—breast cancer	4.35e-06	2.82e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—PIK3CA—breast cancer	4.34e-06	2.81e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CXCL8—breast cancer	4.34e-06	2.81e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—HRAS—breast cancer	4.34e-06	2.81e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—HRAS—breast cancer	4.33e-06	2.8e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—KRAS—breast cancer	4.32e-06	2.8e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—HRAS—breast cancer	4.31e-06	2.79e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CXCL8—breast cancer	4.3e-06	2.79e-05	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—AKT1—breast cancer	4.3e-06	2.78e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CDKN1B—breast cancer	4.28e-06	2.77e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—HRAS—breast cancer	4.27e-06	2.77e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CDKN1B—breast cancer	4.27e-06	2.76e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CASP3—breast cancer	4.26e-06	2.76e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CDKN1B—breast cancer	4.25e-06	2.76e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL2—breast cancer	4.25e-06	2.75e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CDKN1B—breast cancer	4.24e-06	2.75e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—IL6—breast cancer	4.23e-06	2.74e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—AKT1—breast cancer	4.23e-06	2.74e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—SRC—breast cancer	4.23e-06	2.74e-05	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—AKT1—breast cancer	4.22e-06	2.73e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—AKT1—breast cancer	4.21e-06	2.73e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—SRC—breast cancer	4.21e-06	2.72e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TP53—breast cancer	4.2e-06	2.72e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CDKN1B—breast cancer	4.2e-06	2.72e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—AKT1—breast cancer	4.19e-06	2.72e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CASP3—breast cancer	4.19e-06	2.71e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL2—breast cancer	4.19e-06	2.71e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CASP3—breast cancer	4.18e-06	2.71e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL2—breast cancer	4.18e-06	2.7e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CASP3—breast cancer	4.17e-06	2.7e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—IL6—breast cancer	4.16e-06	2.7e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL2—breast cancer	4.16e-06	2.7e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CASP3—breast cancer	4.16e-06	2.69e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—IL6—breast cancer	4.16e-06	2.69e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—AKT1—breast cancer	4.15e-06	2.69e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL2—breast cancer	4.15e-06	2.69e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCND1—breast cancer	4.15e-06	2.69e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—IL6—breast cancer	4.14e-06	2.68e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—JUN—breast cancer	4.14e-06	2.68e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—IL6—breast cancer	4.13e-06	2.67e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—VEGFA—breast cancer	4.12e-06	2.67e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CASP3—breast cancer	4.12e-06	2.67e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL2—breast cancer	4.11e-06	2.66e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CTNNB1—breast cancer	4.11e-06	2.66e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—VEGFA—breast cancer	4.1e-06	2.65e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—IL6—breast cancer	4.09e-06	2.65e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCND1—breast cancer	4.08e-06	2.64e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—STAT3—breast cancer	4.08e-06	2.64e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—JUN—breast cancer	4.07e-06	2.64e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCND1—breast cancer	4.07e-06	2.64e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—JUN—breast cancer	4.06e-06	2.63e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCND1—breast cancer	4.06e-06	2.63e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—STAT3—breast cancer	4.06e-06	2.63e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—JUN—breast cancer	4.05e-06	2.62e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCND1—breast cancer	4.05e-06	2.62e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CTNNB1—breast cancer	4.04e-06	2.62e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—JUN—breast cancer	4.04e-06	2.61e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CTNNB1—breast cancer	4.03e-06	2.61e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MMP9—breast cancer	4.03e-06	2.61e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—HRAS—breast cancer	4.02e-06	2.6e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CTNNB1—breast cancer	4.02e-06	2.6e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CDKN1A—breast cancer	4.01e-06	2.6e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCND1—breast cancer	4.01e-06	2.59e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CTNNB1—breast cancer	4.01e-06	2.59e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PTEN—breast cancer	4e-06	2.59e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—JUN—breast cancer	4e-06	2.59e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CTNNB1—breast cancer	3.97e-06	2.57e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—PIK3CA—breast cancer	3.97e-06	2.57e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MMP9—breast cancer	3.96e-06	2.57e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MMP9—breast cancer	3.95e-06	2.56e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CDKN1A—breast cancer	3.95e-06	2.56e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MMP9—breast cancer	3.94e-06	2.55e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CDKN1A—breast cancer	3.94e-06	2.55e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PTEN—breast cancer	3.94e-06	2.55e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PTEN—breast cancer	3.93e-06	2.55e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MMP9—breast cancer	3.93e-06	2.54e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CDKN1A—breast cancer	3.93e-06	2.54e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PTEN—breast cancer	3.92e-06	2.54e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MAPK8—breast cancer	3.92e-06	2.54e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CDKN1A—breast cancer	3.91e-06	2.53e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—AKT1—breast cancer	3.9e-06	2.53e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PTEN—breast cancer	3.9e-06	2.53e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MAPK3—breast cancer	3.9e-06	2.52e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MMP9—breast cancer	3.89e-06	2.52e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CDKN1A—breast cancer	3.88e-06	2.51e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MAPK3—breast cancer	3.88e-06	2.51e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PTEN—breast cancer	3.87e-06	2.5e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MAPK8—breast cancer	3.85e-06	2.5e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IL6—breast cancer	3.85e-06	2.49e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MAPK8—breast cancer	3.84e-06	2.49e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—AKT1—breast cancer	3.84e-06	2.49e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TP53—breast cancer	3.84e-06	2.48e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—AKT1—breast cancer	3.83e-06	2.48e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MAPK8—breast cancer	3.83e-06	2.48e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—AKT1—breast cancer	3.82e-06	2.47e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MAPK8—breast cancer	3.82e-06	2.47e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—AKT1—breast cancer	3.81e-06	2.47e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MYC—breast cancer	3.79e-06	2.45e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MAPK8—breast cancer	3.78e-06	2.45e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TGFB1—breast cancer	3.78e-06	2.45e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—AKT1—breast cancer	3.77e-06	2.44e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MYC—breast cancer	3.77e-06	2.44e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TGFB1—breast cancer	3.76e-06	2.43e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—SRC—breast cancer	3.71e-06	2.4e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—EGFR—breast cancer	3.71e-06	2.4e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—EGFR—breast cancer	3.69e-06	2.39e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—HRAS—breast cancer	3.67e-06	2.38e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—SRC—breast cancer	3.65e-06	2.37e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—SRC—breast cancer	3.64e-06	2.36e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—SRC—breast cancer	3.63e-06	2.35e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—SRC—breast cancer	3.62e-06	2.35e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—VEGFA—breast cancer	3.62e-06	2.34e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—SRC—breast cancer	3.59e-06	2.32e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—STAT3—breast cancer	3.58e-06	2.32e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—VEGFA—breast cancer	3.56e-06	2.3e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—VEGFA—breast cancer	3.55e-06	2.3e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—AKT1—breast cancer	3.55e-06	2.3e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—VEGFA—breast cancer	3.54e-06	2.29e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—VEGFA—breast cancer	3.53e-06	2.28e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—STAT3—breast cancer	3.52e-06	2.28e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—STAT3—breast cancer	3.51e-06	2.28e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IL6—breast cancer	3.51e-06	2.27e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—STAT3—breast cancer	3.5e-06	2.27e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—KRAS—breast cancer	3.5e-06	2.27e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—VEGFA—breast cancer	3.49e-06	2.26e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—STAT3—breast cancer	3.49e-06	2.26e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—KRAS—breast cancer	3.48e-06	2.26e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—STAT3—breast cancer	3.46e-06	2.24e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MAPK3—breast cancer	3.42e-06	2.21e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MAPK3—breast cancer	3.37e-06	2.18e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MAPK3—breast cancer	3.36e-06	2.17e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MAPK3—breast cancer	3.35e-06	2.17e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MAPK3—breast cancer	3.34e-06	2.16e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MYC—breast cancer	3.33e-06	2.15e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TGFB1—breast cancer	3.32e-06	2.15e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MAPK3—breast cancer	3.3e-06	2.14e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PIK3CA—breast cancer	3.29e-06	2.13e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MYC—breast cancer	3.27e-06	2.12e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MYC—breast cancer	3.27e-06	2.12e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TGFB1—breast cancer	3.26e-06	2.11e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TGFB1—breast cancer	3.26e-06	2.11e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MYC—breast cancer	3.26e-06	2.11e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—EGFR—breast cancer	3.25e-06	2.11e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TGFB1—breast cancer	3.25e-06	2.1e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MYC—breast cancer	3.25e-06	2.1e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—AKT1—breast cancer	3.24e-06	2.1e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TGFB1—breast cancer	3.24e-06	2.1e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PIK3CA—breast cancer	3.22e-06	2.08e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MYC—breast cancer	3.21e-06	2.08e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TGFB1—breast cancer	3.21e-06	2.08e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—EGFR—breast cancer	3.2e-06	2.07e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PIK3CA—breast cancer	3.2e-06	2.07e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—EGFR—breast cancer	3.19e-06	2.07e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—EGFR—breast cancer	3.18e-06	2.06e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—EGFR—breast cancer	3.17e-06	2.06e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—EGFR—breast cancer	3.14e-06	2.04e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TP53—breast cancer	3.11e-06	2.01e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TP53—breast cancer	3.1e-06	2e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—KRAS—breast cancer	3.07e-06	1.99e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—KRAS—breast cancer	3.02e-06	1.96e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—KRAS—breast cancer	3.02e-06	1.95e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—KRAS—breast cancer	3.01e-06	1.95e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—KRAS—breast cancer	3e-06	1.94e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—HRAS—breast cancer	2.98e-06	1.93e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—KRAS—breast cancer	2.97e-06	1.92e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—HRAS—breast cancer	2.96e-06	1.92e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL6—breast cancer	2.85e-06	1.84e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL6—breast cancer	2.83e-06	1.83e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3CA—breast cancer	2.82e-06	1.83e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3CA—breast cancer	2.78e-06	1.8e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3CA—breast cancer	2.77e-06	1.8e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3CA—breast cancer	2.76e-06	1.79e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3CA—breast cancer	2.75e-06	1.78e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TP53—breast cancer	2.73e-06	1.77e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CA—breast cancer	2.73e-06	1.77e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—AKT1—breast cancer	2.69e-06	1.74e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TP53—breast cancer	2.69e-06	1.74e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TP53—breast cancer	2.68e-06	1.74e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TP53—breast cancer	2.67e-06	1.73e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TP53—breast cancer	2.66e-06	1.73e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TP53—breast cancer	2.64e-06	1.71e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—AKT1—breast cancer	2.63e-06	1.7e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—AKT1—breast cancer	2.61e-06	1.69e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—HRAS—breast cancer	2.61e-06	1.69e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—HRAS—breast cancer	2.57e-06	1.66e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—HRAS—breast cancer	2.56e-06	1.66e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—HRAS—breast cancer	2.56e-06	1.66e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—HRAS—breast cancer	2.55e-06	1.65e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—HRAS—breast cancer	2.52e-06	1.63e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL6—breast cancer	2.5e-06	1.62e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL6—breast cancer	2.46e-06	1.59e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL6—breast cancer	2.45e-06	1.59e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL6—breast cancer	2.45e-06	1.58e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL6—breast cancer	2.44e-06	1.58e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL6—breast cancer	2.42e-06	1.56e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—AKT1—breast cancer	2.31e-06	1.49e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AKT1—breast cancer	2.27e-06	1.47e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AKT1—breast cancer	2.26e-06	1.47e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AKT1—breast cancer	2.26e-06	1.46e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AKT1—breast cancer	2.25e-06	1.46e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AKT1—breast cancer	2.23e-06	1.44e-05	CbGpPWpGaD
